Clinion
Clinion is an AI-enabled eClinical platform provider serving pharmaceutical, biotech, medical device, CRO, and academic research organizations with integrated trial management modules deployed across 100+ countries since 2014.
- Company typePrivate
- Founded2014
- HeadquartersAustin, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Clinion does
Clinion is an AI-enabled eClinical platform provider that helps pharmaceutical, biotechnology, medical device, contract research organization (CRO), and academic research organizations design, run, and report on clinical trials. Founded in 2014 and headquartered in Hyderabad, India with sales and operations offices in Austin, Texas (US) and London (UK), the company reports 51-100 employees and a customer base of 100+ organizations across 100+ countries, supporting 655+ trials and 300,000+ subjects cumulatively. The platform's core product surface spans electronic data capture (EDC), randomization and trial supply management (RTSM), clinical trial management system (CTMS), electronic consent (eConsent), electronic patient-reported outcomes (ePRO), electronic source (eSource), electronic trial master file (eTMF), image repository, and AI-assisted protocol and clinical study report (CSR) automation.
Clinion's technical differentiation rests on a Multi-Agentic AI Assistant combined with point AI capabilities including AI Medical Coding for MedDRA and WHODrug dictionaries, computer vision for DICOM image PHI redaction, NLP for protocol authoring and real-world data harmonization, anomaly detection for risk-based source data verification (rSDV), and Gen AI-driven protocol and CSR drafting. The AI stack is built on Azure OpenAI infrastructure, indicating third-party foundation-model dependency. Platform certifications relevant to regulated buyers include SOC 2 Type II, ISO 27001, ISO 9001, ISO 42001 (in progress), HIPAA, GDPR, 21 CFR Part 11, ICH-GCP, and EU Annex 11. The company has received industry recognition including ACDM Awards (2025/2026), Citeline Awards (2021/2025), and Frost & Sullivan recognition (2024).
The business model is quote-based enterprise SaaS sold to regulated buyers, distributed through direct sales to sponsors and academic research organizations plus channel partnerships with CROs (notably Clinevo, July 2024). Revenue is not publicly disclosed, and the company is privately held with no disclosed funding rounds in the available data.
Clinion firmographics
Firmographics- Name
- Clinion
- Legal name
- Clinion AI Technologies Pvt Ltd
- Website
- https://clinion.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Clinion is an AI-enabled eClinical platform provider serving pharmaceutical, biotech, medical device, CRO, and academic research organizations with integrated trial management modules deployed across 100+ countries since 2014.
- Ownership category
- akta.pro rank
Clinion industry classification
Industry- Product category
- Clinical Trial Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Electronic Data Capture (EDC) Platforms (HLACAOAA)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)
Keywords
Where Clinion is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Clinion business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- eClinical Platform Subscription: SaaS-based subscription model providing access to unified platform modules including EDC, RTSM, CTMS, eConsent, ePRO, eSource, eProtocol, CSR, and eTMF. Customers license the platform on a per-study or enterprise basis with different modules available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription pricing - Quote-based |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels9 records
Clinion product offering
Product offeringCore offering
Clinion provides an AI-enabled unified eClinical platform that integrates EDC, RTSM, CTMS, eConsent, ePRO, eSource, eTMF, eProtocol Automation, CSR Automation, and an AI-powered Image Repository into a single system. The platform is built on Azure OpenAI and supports decentralized and hybrid clinical trials with AI capabilities (including Agentic AI, generative AI, AI medical coding, and computer-vision PHI redaction) embedded directly into core workflows rather than offered as add-ons. Customers license modules on a per-study or enterprise subscription basis to manage clinical trial data, randomization, supply logistics, consent, patient-reported outcomes, regulatory documents, and imaging.
Product overview
Clinion offers a unified AI-enabled eClinical platform that integrates multiple modules for end-to-end clinical trial management. The core platform combines EDC (Electronic Data Capture), eProtocol (Protocol Automation), CSR Automation, CTMS (Clinical Trial Management System), RTSM (Randomisation and Trial Supply Management), ePRO, eSource, eConsent, eTMF, Image Repository, and Agentic Assistant into a single cohesive system. The platform is powered by Agentic AI and Gen AI capabilities including AI Medical Coding, predictive analytics, and natural language processing. This integrated approach enables decentralized and hybrid trials while reducing manual processes and costs, supporting over 655 clinical trials across 100+ countries.
Differentiator
Problem solved
Functional benefit
Products and services
- EDC (Electronic Data Capture) AI-driven Electronic Data Capture platform that automates key steps of clinical trials including Study Setup, CDASH mapping, Remote Source Data Verification, AI Medical Coding, Data Review, and Custom Reporting for pharmaceutical sponsors and CROs.
- RTSM (Randomisation and Trial Supply Management) Automated randomization and supply logistics with direct EDC integration, supporting studies from simple to highly complex for sponsors and CROs.
- ePRO (Electronic Patient Reported Outcome) Application for patient-reported data capture through multilingual forms, automated reminders, and seamless EDC integration available on mobile, tablet, or web for clinical trial participants.
- eSource Real-time source data capture solution with built-in validations, full traceability, and EDC integration for clean, compliant data from first capture to database lock.
- eConsent Informed Consent solution with multimedia forms, real-time tracking, and patient-friendly UX supporting both onsite and remote consent for clinical trial sites.
- CTMS (Clinical Trial Management System) Centralized Clinical Trial Management System that unifies project tracking, site monitoring, and financials with real-time visibility and operational clarity for CROs and sponsors.
- eTMF (Electronic Trial Master File) Digital trial document management with pre-built DIA reference models, real-time tracking, version control, bulk uploads, and robust audit trails for regulatory documentation.
- eProtocol (Protocol Automation) AI auto-generates ICH M11 and TranCelerate-compliant protocol drafts from study summaries in minutes, automating draft generation, collaboration, review, and finalization on a single platform for sponsors and CROs.
- CSR Automation AI-powered solution that generates high-quality Clinical Study Reports by extracting key insights from Protocol, SAP, and TLFs, auto-populating up to 70% of CSR while ensuring ICH E3 compliance.
- Image Repository DICOM Image Repository enabling upload, de-identification, storage, and management of trial imaging data within EDC with AI-powered PHI redaction in under 30 seconds for clinical trial teams.
- Agentic Assistant Multi-Agentic AI assistant enabling users to access protocol knowledge, operational metrics, and live clinical data through natural language conversations embedded within EDC for clinical data management teams.
Quantifiable outcome
- Reduces trial costs by 35% and accelerates time-to-market by 30%
- +4 more outcomes
Companies that use Clinion
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Clinion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability11 records
Feature8 records
Clinion partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ClinevocoreStrategic alliance for an integrated eClinical experience. Clinevo and Clinion partnered to deliver combined solutions that enhance clinical trial operations and data management capabilities for mutual customers.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
Clinion competitors and assessment
Company assessmentDirect peers
- Signant Health: Signant Health provides eCOA/ePRO, RTSM, patient engagement, and clinical outcome assessment solutions — comparable patient-facing data collection and supply technology to Clinion's ePRO and RTSM modules.
- ArisGlobal: ArisGlobal's LifeSphere platform spans clinical trial management, safety, regulatory, and medical affairs — a comparable end-to-end clinical technology play targeting global pharma.
- Castor: Castor offers a unified eClinical platform with EDC, ePRO, eConsent, and decentralized trial capabilities, targeting similar mid-market sponsors and academic researchers as Clinion.
- Veeva Systems: Veeva's Vault Clinical Suite (EDC, CTMS, eTMF, RTSM, Payments) is the most direct competitor to Clinion's unified eClinical platform, targeting the same pharma/CRO sponsors with cloud-native, compliance-heavy SaaS.
- Y-Prime: Y-Prime specializes in IRT/RTSM and clinical trial technology, overlapping with Clinion's RTSM module and broader eClinical positioning for pharma and biotech sponsors.
- Medrio: Medrio provides cloud-based EDC, ePRO, and eConsent for clinical trials, often used by mid-sized sponsors and CROs — overlapping significantly with Clinion's customer profile and product suite.
- Medidata (Dassault Systèmes): Medidata's Rave platform (EDC, RTSM, CTMS, eCOA, Imaging) is the category leader in eClinical technology and the most comparable suite to Clinion's integrated offering.
- Oracle Clinical One: Oracle Clinical One is a unified clinical trial platform spanning EDC, RTSM, CTMS, and supply management — directly comparable to Clinion's single-platform approach.
Emerging players
- Medable: Medable is a leading decentralized clinical trial platform with eCOA, eConsent, telehealth, and remote data capture — overlapping with Clinion's decentralized/hybrid trial capabilities and patient-facing modules.
- Saama Technologies: Saama applies AI and analytics across clinical development (study startup, patient journey, regulatory submissions) — a comparable AI-for-clinical-trials positioning that overlaps with Clinion's Gen AI and Agentic AI roadmap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Clinion social profiles
Digital presenceClinion compliance and trust
Trust signalCompliance9 records
Clinion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinion leadership team
Management profileNumber of profiles
Profiles3 records
Clinion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinion
What does Clinion do?
Clinion provides an AI-enabled unified eClinical platform that integrates EDC, RTSM, CTMS, eConsent, ePRO, eSource, eTMF, eProtocol Automation, CSR Automation, and an AI-powered Image Repository into a single system. The platform is built on Azure OpenAI and supports decentralized and hybrid clinical trials with AI capabilities (including Agentic AI, generative AI, AI medical coding, and computer-vision PHI redaction) embedded directly into core workflows rather than offered as add-ons. Customers license modules on a per-study or enterprise subscription basis to manage clinical trial data, randomization, supply logistics, consent, patient-reported outcomes, regulatory documents, and imaging.
Is Clinion a public or private company?
Clinion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clinion founded?
Clinion was founded in 2014. It employs 51 to 100 people.
Where is Clinion based?
Clinion is headquartered in Austin, United States, in the North America region.
How does Clinion make money?
One revenue line is on record: eClinical Platform Subscription.
Who are Clinion's main competitors?
Direct peers on record are Signant Health, ArisGlobal, Castor, Veeva Systems, Y-Prime, Medrio, Medidata (Dassault Systèmes) and Oracle Clinical One. Emerging players are Medable and Saama Technologies.
Does Clinion have an API?
No public API is recorded for Clinion.
What industry is Clinion in?
Clinion's product category is Clinical Trial Software. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms, with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 5132 and its SIC code is 7372.